Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs.

Tilmicosin(TM), a macrolide antibiotic and active ingredient in formulated Micotil 300 (Eli Lilly and Co., Indianapolis, IN, USA), is the active ingredient in a formulated animal product used for the treatment of respiratory tract infections in cattle. Owing to the concern of governmental regulatory agencies over the possibility of an accidental injection of the antibiotic to a livestock handler, the cardiovascular effects of sub lethal doses of TM were evaluated in conscious mixed-breed dogs. Left ventricular function, systemic arterial blood pressure, and heart rate (HR) responses to TM alone and in combination with propranolol(P) or dobutamine HCl(DOB) were evaluated. Dogs were instrumented with indwelling micromanometers implanted in the left ventricular chamber and in the thoracic aorta. Cardiovascular variables were recorded, and the peak value of the first derivative of left ventricular pressure (dp/dt(max)) was used as an index of left ventricular inotropic state. Six treatments were randomly assigned to each of the six dogs using a Latin square design. The six treatments were vehicle, TM alone (2.5 mg/kg of body weight), TM immediately followed by P, and TM immediately followed by 1 of 3 dosages of DOB infused for approximately 45 min. Additionally, doses of TM alone (0.25, 1.0, 2.5, and 5.0 mg/kg) were administered to complete a dose-response curve. TM caused dose dependent decreases in (dp/dt(max)) and aortic pulse pressure. HR increased dose-dependently. Left ventricular end-diastolic pressure increased at the 2.5 and 5.0 mg/kg dosages. Left ventricular systolic pressure was reduced dose-dependently at the 2.5 and 5.0 mg/kg dosages. Treatment with P exacerbated the negative inotropic effect and the decrease in left ventricular systolic pressure, but did not attenuate the tachycardia associated with TM treatment. DOB attenuated the changes in ventricular inotropic state in a dose-dependent manner. DOB infusion also restored left ventricular systolic pressure at dosages of 3 or 10 micrograms/min/kg. Our data indicate that toxic doses of TM may have a negative inotropic effect in conscious dogs. HR increased in a dose-dependent manner and was not the result of beta 1-receptor stimulation. DOB reversed some, but not all, of the effects caused by TM administration.

[1]  S. Lavine,et al.  Effect of inotropic and vasodilator therapy on left ventricular diastolic filling in dogs with severe left ventricular dysfunction. , 1990, Journal of the American College of Cardiology.

[2]  J. Carroll,et al.  Role of adrenoceptors and dopamine receptors in modulating left ventricular diastolic function. , 1988, Circulation research.

[3]  H. Boddeke,et al.  Investigation of the Mechanism of Negative Inotropic Activity of Some Calcium Antagonists , 1988, Journal of cardiovascular pharmacology.

[4]  J. Carroll,et al.  The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. , 1986, Circulation.

[5]  J W Tukey,et al.  Testing the statistical certainty of a response to increasing doses of a drug. , 1985, Biometrics.

[6]  W. Miller,et al.  Regional End‐Systolic Pressure‐Length Relationships Using a Volume‐Loading Technique in the Intact Pig Heart , 1984, Circulation research.

[7]  J. Tamargo,et al.  A comparison of josamycin with macrolides and related antibiotics on isolated rat atria. , 1982, European journal of pharmacology.

[8]  D. Harrison,et al.  Comparison of dobutamine and dopamine in treatment of severe heart failure. , 1977, British heart journal.

[9]  R. Tuttle,et al.  Dobutamine: DEVELOPMENT OF A NEW CATECHOLAMINE TO SELECTIVELY INCREASE CARDIAC CONTRACTILITY , 1975, Circulation research.

[10]  S. Yamada,et al.  Effects of several macrolide antibiotics on blood pressure of dogs. , 1972, Japanese journal of pharmacology.